About Srikar Laboratories Private Limited
Data last updated:
Srikar Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2011PTC072844. Its GSTIN is 37AAQCS3754A1Z8 (Andhra Pradesh).
The company has an authorised share capital of ₹6.99 Cr and a paid-up capital of ₹6.99 Cr. It is led by directors including Vijender Medamoni (Managing Director) and Murali Krishnam Raju Vadlamudi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F No.103 1 – 2 – 10/4/103 Evr Shraddha Enclave Apts. Street No.2 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.62 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹3.55 Cr (net margin 4.9%) and EBITDA of ₹9.31 Cr (EBITDA margin 12.8%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 9% over five years.
The company has about 148 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SRIKAR Labs. As per MCA filings, the company has open charges of ₹27.21 Cr and satisfied charges of ₹17.25 Cr on record. Court records list 15 cases involving the company, including 1 filed by the company and 14 filed against it; 7 cases are pending. The company has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹6 Cr; the latest was in December 2023. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Shiva Biogenetic Laboratories Private Limited with revenue of ₹73.64 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srikarlabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressF No.103 1 – 2 – 10/4/103 Evr Shraddha Enclave Apts. Street No.2 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Srikar Laboratories Private Limited
The main business activity of Srikar Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Srikar Laboratories Private Limited FY 2025 filings available
Srikar Laboratories Private Limited reported revenue of ₹72.62 Cr (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Srikar Laboratories Private Limited
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Srikar Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.31 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.55 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Srikar Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Srikar Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Srikar Laboratories Private Limited
Srikar Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shiva Biogenetic Laboratories Private Limited | ₹73.64 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Baddi, Himachal Pradesh, India |
| Ramson Medical Distributors Private Limited | ₹73.14 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Chennai, Tamil Nadu, India |
| Avn Ayurveda Formulations Private Limited | ₹72.9 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Madurai, Tamil Nadu, India |
| Eskay Herbal Formulations Private Limited | ₹72.88 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Jalgaon, Maharashtra, India |
| Kyowa Hakko Bio India Private Limited | ₹72.82 Cr (FY 2020) | •••• | •••• | 74.0% | •••• | Mumbai, Maharashtra, India |
| Srikar Laboratories Private Limited this company | ₹72.62 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Elan Pharma (India) Private Limited | ₹72.61 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Akesiss Pharma Private Limited | ₹72.51 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Kochi, Kerala, India |
| Abhiflax Pharma-Chem Private Limited | ₹72.42 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Vance and Health Pharmaceuticals Private Limited | ₹72.08 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| Walpar Nutritions Limited Listed | ₹72.03 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Gandhinagar, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Srikar Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Srikar Laboratories Private Limited
Srikar Laboratories Private Limited is audited by Vennapusa & Sunkara for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Vennapusa & Sunkara | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Srikar Laboratories Private Limited
Srikar Laboratories has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishnam Raju Vadlamudi Also directs: KRR Drugs and Chemicals Private Limited | Director | 23 Feb 2011 | 15 Years 7 Months | Current |
| Satyanarayana Raju Kanteti | Director | 30 Nov 2020 | 5 Years 10 Months | Current |
| Sandeep Reddy Veerlapally | Director | 19 Nov 2022 | 3 Years 10 Months | Current |
| Vijender Medamoni | Managing Director | 04 Aug 2025 | 1 Years 2 Months | Current |
Ownership and Shareholding of Srikar Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Srikar Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2019 | Hdfc Bank Limited | ₹27.21 Cr | Open |
| 31 Oct 2016 | Others | ₹50 Lakh | Satisfied |
| 30 Dec 2011 | Others | ₹16.75 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Srikar Laboratories Private Limited
Srikar Laboratories Private Limited has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹6 Cr; the latest was in December 2023.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Keminntek Pharmaceuticals LLP |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP & Vadlamudi Murali Krishnam Raju, Keminntek Pharmaceuticals LLP Seller: 2 individuals |
| May 2020 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP Seller: an individual |
| May 2020 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP Seller: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP Seller: 4 individuals |
Full deal history
All 10 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Srikar Laboratories Private Limited
Srikar Laboratories Private Limited has 15 court cases on record: 1 filed by Srikar Laboratories, 14 filed against it. 7 cases are pending and 8 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 14 | 7 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed against the company by Cocreate Global Technologies Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (CC.NI) | Filed against the company by Sesa Chem India Private Limited | Disposed |
| District court, Bharuch, Gujarat | Civil suit | Filed against the company by Organic Industries Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Sesa Chem India Private Limited | Disposed |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed against the company by an individual | Pending |
Full case history
All 15 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Srikar Laboratories Private Limited
Srikar Laboratories operates one associated brand: SRIKAR Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical API manufacturing and contract services in India. | srikarlabs.com |
Employees and EPFO Compliance at Srikar Laboratories Private Limited
Srikar Laboratories Private Limited has a workforce of 148 employees as of Sep 25, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Srikar Laboratories Private Limited
Srikar Laboratories has one previous CIN (Corporate Identification Number): U24100AP2011PTC072844. The current CIN is U24100TG2011PTC072844, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2011PTC072844 | Current |
| U24100AP2011PTC072844 | Previous |
Recent Activity on Srikar Laboratories Private Limited
Srikar Laboratories Private Limited has 22 board changes on record since 2011: 13 appointments and 9 cessations. The latest: Vijender Medamoni was appointed as Managing Director on 04 Aug 2025.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Srikar Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Srikar Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Srikar Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Srikar Laboratories Private Limited
Srikar Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAQCS3754A1Z8 | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Srikar Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srikar Laboratories Private Limited
Srikar Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 February 2011 (15+ years old) and is registered under CIN U24100TG2011PTC072844.
Srikar Laboratories reported revenue of ₹72.62 Cr for FY 2025 (down 10% YoY).
Srikar Laboratories has 4 current directors:
- Vijender Medamoni - Managing Director
- Murali Krishnam Raju Vadlamudi - Director
- Satyanarayana Raju Kanteti - Director
- Sandeep Reddy Veerlapally - Director
Srikar Laboratories reported a net profit of ₹3.55 Cr (net margin 4.9%) and EBITDA of ₹9.31 Cr (EBITDA margin 12.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Srikar Laboratories is 4% over three years and 9% over five years. In the latest year (FY 2025) revenue fell 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Srikar Laboratories is 37AAQCS3754A1Z8, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Srikar Laboratories is U24100TG2011PTC072844. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srikar Laboratories has 15 court cases on record: 1 filed by the company and 14 filed against it. 7 are pending. Most are in the district courts.
Srikar Laboratories was incorporated on 23 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srikar Laboratories has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹6 Cr; the latest was in December 2023.
The peers of Srikar Laboratories by revenue are Shiva Biogenetic Laboratories Private Limited, Ramson Medical Distributors Private Limited, Avn Ayurveda Formulations Private Limited, Eskay Herbal Formulations Private Limited, Kyowa Hakko Bio India Private Limited and 5 more, all in the Pharma industry (Formulations).